{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:41:49Z","timestamp":1759412509482},"reference-count":19,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.03.037","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T15:17:29Z","timestamp":1428419849000},"page":"2342-2346","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen"],"prefix":"10.1016","volume":"33","author":[{"given":"Jon","family":"Oscherwitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemp B.","family":"Cease","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.03.037_bib0105","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1086\/518151","article-title":"Project BioShield: what it is, why it is needed, and its accomplishments so far","volume":"45","author":"Russell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0115","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0120","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"87","author":"Pitt","year":"1999","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0130","doi-asserted-by":"crossref","first-page":"151ra26","DOI":"10.1126\/scitranslmed.3004073","article-title":"Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge","volume":"4","author":"Fay","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0135","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2003.09.003","article-title":"Validation of the anthrax lethal toxin neutralization assay","volume":"32","author":"Hering","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0145","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.300.13.1532","article-title":"Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial","volume":"300","author":"Marano","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/CVI.00612-12","article-title":"Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax","volume":"20","author":"Oscherwitz","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0155","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.1001749","article-title":"A synthetic peptide vaccine directed against the 2\u03b22-2\u03b23 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax","volume":"185","author":"Oscherwitz","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0160","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.vaccine.2014.11.042","article-title":"Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax","volume":"33","author":"Oscherwitz","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0165","doi-asserted-by":"crossref","first-page":"22090","DOI":"10.1074\/jbc.M010222200","article-title":"A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo","volume":"276","author":"Singh","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0170","doi-asserted-by":"crossref","first-page":"29039","DOI":"10.1016\/S0021-9258(19)62010-7","article-title":"The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor","volume":"269","author":"Singh","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0175","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"Rosovitz","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0180","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/IAI.00358-09","article-title":"Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen","volume":"77","author":"Oscherwitz","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0185","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1128\/IAI.00899-09","article-title":"A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen","volume":"77","author":"Oscherwitz","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0195","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.037_bib0200","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1128\/IAI.01254-08","article-title":"Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed","volume":"77","author":"Reason","year":"2009","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T14:26:35Z","timestamp":1651674395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15003369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":19,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15003369"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}